Join Chamber Hill Strategies’ Melissa Bartlett for a panel discussion on CURES 2.0 Legislation and Patient-Focused Drug Development Opportunities as part of the BIO CEO & Investor Conference next week.
Melissa Bartlett, principal, presented on the changing regulatory landscape for oncologist practices at the annual meeting of the Association of Cancer Executives.
Melissa Bartlett, a former lobbyist for Sanofi, has left the biotech company to join the lobbying firm Chamber Hill Strategies. Her résumé also includes working at Health Care Service Corporation (HCSC) and time on Capitol Hill as GOP counsel to the House Energy and Commerce Committee.